MEGACE 160 mg, tablet 30 tablets
Active ingredients: Megestrol acetate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablet30 tabletsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- MEGACE 160 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- BAUSCH HEALTH IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1994
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67448384CIP73360472CIP133400933604721Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉGESTROL (ACÉTATE DE)comprimé | 160 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.